You searched for "device"
New Procedure to Revolutionise Paediatric Ear Surgery Performed for the First Time using AventaMed Solo + Tympanostomy Tube Device (TTD)
AventaMed DAC, a Cork, Ireland company announced the first use of its Solo+ TTD in a paediatric patient while the patient was awake.
Cochlear implanted children are more likely to have device failure if their balance function is impaired
We know that children with permanent hearing loss are more likely to have an associated balance problem. It is also thought that children with cochlear implants (CI) that fail do so because of an increased risk of falls and head...The EU Medical Device Regulation (MDR)
Back in May 2017, the EU Medical Device Regulation (MDR 2017/745) entered into force, replacing existing directives: Active Implantable Medical Devices (AIMD) In-vitro Diagnostic Directive (IVDD) Medical Device Directive (MDD) By 26 May 2020, the new regulation will have completed...
Controlling tinnitus
The absence of sufficient evidence for the use of integrated sound generators for the management of tinnitus led the authors to conduct a randomised blind clinical trial in which they compared the use of a conventional hearing aid with a...
Learning from reimplantation
The Irish implant centre in Dublin undertook a retrospective study of their reimplantation cases to look at what lessons could be learnt. Device failures fall into two classes: hard and soft failures. Hard failures are implant malfunction or altered performance....
International consensus paper on implantable devices for conductive or mixed loss
This is a weighty but insightful ‘Special Feature’ paper in the June edition of Otology and Neurotology. It has the broad aim to gather current opinion from otologists, audiologists, manufacturers and health-economists from around the world on unilateral hearing implantation...
Early results of the Cochlear Osia (active transcutaneous bone-conduction implant) in teenagers
This funded research trial involving 14 adolescents, aged 10 to 17 years, in the Toronto Hospital for Sick Kids was carried out just prior to the new Osia implant obtaining FDA approval for use in the USA. The majority had...
Neuromodulation in drug resistant epilepsy
Treatment of epilepsy can be considered generally as medical or surgical. Anti-epileptic drugs achieve a five-year seizure freedom in 54-70% patients. It is estimated that 50-90% of patients with drug-refractory epilepsy may not be candidates for resective surgery. For example,...
